Alternativen zu HCG (Human Chorionic Gonadotropin)

A racemic selective estrogen receptor modulator (SERM) that has been FDA-approved for decades for female ovulation induction, and is used off-label in men with secondary (low-LH) hypogonadism to raise endogenous testosterone. By blocking estrogen feedback at the hypothalamus it increases LH and FSH, driving the testes to make more testosterone — unlike testosterone gels/injections, which suppress both. Honest appraisal: clomiphene is the RACEMIC mixture of enclomiphene (trans, the active estrogen-antagonist isomer) and zuclomiphene (cis, a long-lived weakly estrogenic isomer that accumulates) — the zuclomiphene downside is the entire reason the single-isomer enclomiphene was developed. Male use is off-label, the evidence is mostly observational and surrogate-based (testosterone/LH/FSH), and there are NO long-term hard-outcome trials. It is NOT a longevity drug.

The trans-isomer of clomiphene — a selective estrogen receptor modulator (SERM) used off-label/investigationally as a testosterone therapy. By blocking estrogen feedback at the hypothalamus it raises LH, FSH, and endogenous testosterone while preserving sperm production, unlike exogenous testosterone, which suppresses both. Honest appraisal: Phase-2/3 RCTs show it raises testosterone and keeps sperm counts in the normal range vs topical testosterone — but it is NOT FDA-approved (Androxal failed to gain approval) and is compounded/off-label, and there are NO long-term hard-outcome trials (cardiovascular, bone, mortality).

A lipid-soluble antioxidant central to mitochondrial energy production, with the strongest trial support for fertility/IVF outcomes and heart failure.

Converts carbohydrates into energy and is needed for nerve function. Deficiency causes serious brain disorders, while extra thiamine is not shown to sharpen thinking.

Hormone-like vitamin that regulates 1,000+ genes — deficiency is widespread and linked to poor immunity, depression, and bone loss.

Vitamin-like compound studied for hormonal and metabolic balance. Best evidence is for PCOS and gestational-diabetes prevention (multiple meta-analyses, though recent high-quality trials are mixed); anxiety/OCD data are older and thinner.

Bioactive folate that bypasses MTHFR conversion — critical for the 30-40% of people with gene variants affecting mood and methylation.

Nutritional insurance that fills micronutrient gaps. In the large COSMOS trial, a daily multivitamin improved memory and slowed cognitive decline in older adults — but it did not reduce total cancer, cardiovascular disease, or mortality.